Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income…
The US (and other high-income countries) are not included in that licensing deal, meaning the non-insured in those countries will hafta wait for the domestic patent protections to expire (2034-2041) or be successfully challenged in the courts.
The US (and other high-income countries) are not included in that licensing deal, meaning the non-insured in those countries will hafta wait for the domestic patent protections to expire (2034-2041) or be successfully challenged in the courts.
Ok that’s indeed steep then 😢